RPRX

NASDAQ

Royalty Pharma Plc · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$30.64B

PE Ratio

28.131

EV to Ebitda

21.1494

Earnings Yield

3.55%

Revenue (TTM)

$2.38B

Net Income (TTM)

$1.32B

Revenue (Annual YoY Growth)

5.06%

Revenue (Quarterly YoY Growth)

4.71%

Profit Margin

55.68%

Return on Equity

13.52%

Debt to Equity Ratio

1.3845

Dividend Yield

1.24%

All fundamentals

Core10 fields›

Market Cap$30.64B

Revenue TTM$2.38B

Shares Outstanding428.4M

Float379379535

Float Short2.74%

Days To Cover3.7564610642

Short Interest11943695.0

Institutional Ownership59.42%

Relative Strength84

GARP1990

Growth Estimates19 fields›

Revenue Growth (Annual)5.06%

Revenue Growth (Quarterly YoY)4.71%

Operating Revenue Growth (Annual)0.045248

Operating Revenue Growth (Quarterly YoY)-0.003783

3-Year Revenue Growth2.06%

5-Year Revenue Growth2.30%

EPS Growth (Annual)-6.83%

EPS Growth (Quarterly YoY)6.83%

3-Year EPS Growth Rate163.11%

5-Year EPS Growth Rate-7.26%

LT EPS Growth Estimates9.36%

EBITDA Growth (Annual)20.96%

EBITDA Growth (Quarterly YoY)7.81%

CFO Growth (Annual)-7.08%

CFO Growth (Quarterly YoY)11.58%

FCF Growth (Annual)233.64%

FCF Growth (Quarterly YoY)-60.51%

Dividend Growth (Annual)4.76%

Dividend Growth (Quarterly YoY)4.76%

Operations28 fields›

Revenue TTM$2.38B

Gross Margin TTM51.67%

Gross Margin (Quarterly)99.81%

R&D % of Revenue TTM19.03%

R&D Expenses TTM$452.5M

Operating Margin TTM65.56%

Operating Margin (Quarterly)62.38%

Operating Expenses TTM$-330.3M

Profit Margin TTM55.68%

Profit Margin (Quarterly)57.23%

Net Income TTM$1.32B

EPS TTM1.7806

EPS (Quarterly)0.4992

EBIT Margin TTM65.56%

EBIT Margin (Quarterly)62.38%

EBITDA Margin TTM65.66%

EBITDA Margin (Quarterly)62.57%

EBITDA TTM$1.56B

CFO % of Revenue TTM109.12%

CFO % of Revenue (Quarterly)133.78%

CFO TTM$2.59B

Cash Margin109.22%

Capex % of Revenue TTM71.39%

Capital Expenditures$1.70B

FCF % of Revenue TTM37.73%

FCF % of Revenue (Quarterly)15.83%

FCF TTM$897.2M

Fundamental Score7

Efficiency6 fields›

ROE13.52%

ROA7.11%

ROIC7.34%

CROCI4.98%

Stock Comp % (Quarterly)20.22%

Stock Comp % TTM12.19%

Valuation20 fields›

P/E (TTM)28.131

P/E Forward9.8199

P/E Ex-Cash27.2953

P/S Forward6.2692

PEG Forward0.0527

P/CFO10.2723

P/FCF29.7092

EV/EBITDA (TTM)21.1494

EV/EBITDA Forward10.2972

EV/Revenues (TTM)13.8874

EV/Revenues Forward9.6485

EV/CFO10.8407

EV/FCF (TTM)36.8095

Price To Book3.3132

Price to Tangible Book2.9777

Earnings Yield3.55%

FCF Yield3.37%

Dividend Yield1.24%

Payout Ratio44.07%

Value Score5

Relative to Industry10 fields›

Relative Gross Margin (Quarterly)1.2787

Relative P/E1.9203

Relative P/S1.8272

Relative P/B0.7424

Relative Earnings Yield0.5208

Relative Dividend Yield1.7125

Relative ROE0.4053

Relative ROA0.402

Relative ROIC0.3015

Relative Debt to Equity4.0529

Liquidity15 fields›

Cash Per Share1.4872

Current Ratio2.4019

Cash & ST Assets$637.5M

Total Debt$8.97B

Goodwill & Intangibles$17.13B

Total Assets$19.62B

Total Liabilities$9.91B

Shareholders Equity$6.48B

Debt to Equity1.3845

Debt to Assets46.07%

Interest Expense$307.7M

Times Interest Earned5.0677

CFO to Debt (TTM)0.3151

Debt to EBITDA (TTM)5.3294

Goodwill % of Assets87.32%

Yields5 fields›

Dividend Yield1.24%

Payout Ratio44.07%

Earnings Yield3.55%

Buyback Yield5.72%

Shareholder Yield8.05%

Options Flow8 fields›

Call Volume965

Put Volume2

Put/Call Ratio0.002072538860103627

Call $ Volume91825

Put $ Volume64

Put/Call $ Ratio0.0006969779471821399

Call OI9767

Put OI1773